Related references
Note: Only part of the references are listed.Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis
Neil C. Henderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The prolonged life-span of alveolar macrophages
Jaime Murphy et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Disorders of Lysosome-Related Organelle Biogenesis: Clinical and Molecular Genetics
Marjan Huizing et al.
Annual Review of Genomics and Human Genetics (2008)
Progressive preclinical interstitial lung disease in rheumatoid arthritis
Bernadette R. Gochuico et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring
Ryoichi Mori et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Early interstitial lung disease in familial pulmonary fibrosis
Ivan O. Rosas et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis
Lisa R. Young et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis
Christopher P. Baran et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis
Ping Ren et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Pulmonary fibrosis in Hermansky-Pudlak syndrome is not fully usual
Vincent Thomas de Montpreville et al.
ANNALES DE PATHOLOGIE (2006)
A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8)
NV Morgan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome
DJ Lederer et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
A Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis
A Capelli et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Lung pathology of pale ear mouse (model of Hermansky-Pudlak syndrome 1) and beige mouse (model of Chediak-Higashi syndrome): Severity of giant lamellar body degeneration of type II pneumocytes correlates with interstitial inflammation
XY Tang et al.
PATHOLOGY INTERNATIONAL (2005)
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice
I Inoshima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Characterization of BLOC-2, a complex containing the Hermansky-Pudlak syndrome proteins HPS3, HPS5 and HPS6
SM Di Pietro et al.
TRAFFIC (2004)
Hermansky-Pudlak syndrome type 4 in a patient from Sri Lanka with pulmonary fibrosis
EB Bachli et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Inflammatory response and cathepsins in silica-exposed Hermansky-Pudlak syndrome model pale ear mice
Y Yoshioka et al.
PATHOLOGY INTERNATIONAL (2004)
Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)
W Li et al.
NATURE GENETICS (2003)
BLOC-3, a protein complex containing the Hermansky-Pudlak syndrome gene products HPS1 and HPS4
JA Martina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biogenesis of lysosome-related organelles complex 3 (BLOC-3):: A complex containing the Hermansky-Pudlak syndrome (HPS) proteins HPS1 and HPS4
R Nazarian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis
S Nagai et al.
INTERNAL MEDICINE (2002)
Hermansky-Pudlak Syndrome Type 1: Gene Organization, Novel Mutations, and Clinical-Molecular Review of Non-Puerto Rican Cases
Christina R. Hermos et al.
HUMAN MUTATION (2002)
Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome
WA Gahl et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Pirfenidone suppresses tumor necrosis factor-α, enhances interleukin-10 and protects mice from endotoxic shock
H Oku et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Nonsense mutations in ADTB3A cause complete deficiency of the β3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2
M Huizing et al.
PEDIATRIC RESEARCH (2002)
Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation
SN Iyer et al.
INFLAMMATION (2000)
Molecular characterization of the protein encoded by the Hermansky-Pudlak syndrome type 1 gene
EC Dell'Angelica et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1
M Brantly et al.
CHEST (2000)
Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals
HP Misra et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes
Y Nakatani et al.
VIRCHOWS ARCHIV (2000)
Share Paper
